PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23070058-1	2013	AIMS/HYPOTHESIS: Downregulation of levels of endothelial progenitor cells (EPCs) during in-vitro short-term exposure to high glucose concentrations relates to reduced activity of silent information regulator 1 (SIRT1) and increased synthesis of platelet-activating factor (PAF).	Glucose	125-132	sirtuin 1	Homo sapiens	179-209	
23070058-1	2013	AIMS/HYPOTHESIS: Downregulation of levels of endothelial progenitor cells (EPCs) during in-vitro short-term exposure to high glucose concentrations relates to reduced activity of silent information regulator 1 (SIRT1) and increased synthesis of platelet-activating factor (PAF).	Glucose	125-132	sirtuin 1	Homo sapiens	211-216	
23070058-2	2013	We investigated the possible relationship between PAF and SIRT1 pathways in EPCs during altered glucose homeostasis.	Glucose	96-103	sirtuin 1	Homo sapiens	58-63	
23070058-5	2013	In-vitro experiments with the PAF-R antagonist CV3988 were performed on EPCs isolated from leucocyte-rich buffy coat of healthy human donors.	CV 3988	47-53	platelet activating factor receptor	Homo sapiens	30-35	
23070058-9	2013	In-vitro experiments confirmed that EPCs respond to PAF stimulation with decreased SIRT1 protein and SIRT1 mRNA levels.	Platelet Activating Factor	52-55	sirtuin 1	Homo sapiens	83-88	
23070058-9	2013	In-vitro experiments confirmed that EPCs respond to PAF stimulation with decreased SIRT1 protein and SIRT1 mRNA levels.	Platelet Activating Factor	52-55	sirtuin 1	Homo sapiens	101-106